MARTIN KATZMAN M.D. F.R.C.P.(C)
32 Park Road
Toronto, Ontario Canada M4W 2N4
Phone: (416) 598-9344
Fax: (416) 598-8198
Dr. Katzman is the Clinic Director and Staff Psychiatrist at the S.T.A.R.T. Clinic (Stress, Trauma, Anxiety, Rehabilitation and Treatment) for Mood and Anxiety Disorders. He is also a faculty member at the Northern Ontario School of Medicine (Laurentian University and Lakehead University). He is also appointed in the Department of Psychology at Lakehead University and is a member of the Faculty of Psychology at Adler School of Professional Studies.
Dr. Katzman was trained at the University of Toronto, first undertaking his B.Sc. in Psychology and Neuroscience, and subsequently his medical training and residency.
Dr. Katzman’s clinical work deals chiefly with the diagnosis and treatment of adults suffering with mood and anxiety disorders, as well as those suffering with chronic Attention Deficit Disorders, Executive Dysfunction as well as chronic pain, providing expert diagnostic assessment, and pharmacological treatment as well as Cognitive Behavioural Therapy in both group and individual formats, psychodynamic treatment and Mindfulness Based treatments.
As an educator, Dr. Katzman has developed numerous training programs for both students and clinicians including medical students and residents, primary care physicians, psychiatrists, psychologists, social workers, occupational therapists, nurses, a variety of support workers as well as naturopaths, and other complementary and alternative medicine clinicians.
His research primarily involves examining the psychological manifestations associated with executive dysfunction in the mood, anxiety and traumatic disorders. Most recently, his specific recent interest has involved examining the role of “Intolerance of Uncertainty” as a driver of psychopathology and the role of hedonic tone in predicting the presence of comorbid conditions and differential response to treatment. In the past he has used such varied tools as positron emission tomography, the respiratory physiological challenge, and Doppler imaging, in association with a variety of anxiogenic challenges.
Dr. Katzman is also a founding member of the Board of Directors as well as the founding and current Chair of the Scientific Advisory Board of the Anxiety Disorders Association of Canada/Association Canadienne des Troubles Anxieux (ADAC/ACTA).
He is the chair of a variety of scientific advisory boards, on the editorial board for a number of journals, and has published numerous papers in the areas of Anxiety, Mood, Pain and Attention Disorders.
The focus of his research has been related to Hypoprefrontality, Executive Dysfunction, Intolerance of Uncertainty and Low Hedonic Tone in relation to the development of a variety of comorbidities in association with treatment resistance.
Most Recent Publications
1. Fallu A, Dabouz F, Furtado M, Anand L, Katzman MA. A randomized, double-blind, cross-over, phase IV trial of Oros-Methylphenidate (Concerta®) and generic Novo-Methylphenidate ER-C (NOVO-generic). Accepted to Therapeutic Advances in Psychopharmacology.
2. Montoya A, Bruins R, Katzman MA, Blier P. The noradrenergic paradox: implications in the management of depression and anxiety. Neuropsychiatric Disease and Treatment. 2016:12 541-547.
3. Furtado M, Katzman MA. Examining the Role of Neuroinflammation in Major Depression. Psychiatry Research. 2015, 229:27-36.
4. Furtado M, Katzman MA. Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Research. 2015, 229:37-48.
5. Logan AC, Katzman MA, Balanzá-Martínez V. Natural environments, ancestral diets and microbial ecology: is there a modern “paleo- deficit disorder”? Part I. Journal of Physiological Anthropology. 2015, 34(1):1.
6. Logan AC, Katzman MA, Balanzá-Martínez V. Natural environments, ancestral diets and microbial ecology: is there a modern “paleo- deficit disorder”? Part II. Journal of Physiological Anthropology. 2015, 34(1): 9.
7. Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M for the Canadian Anxiety Guidelines Initiative Group. Canadian clinical practice guidelines for the management of anxiety, post-traumatic stress, and obsessive-compulsive disorders. BMC Psychiatry. 2014, 14(Suppl 1):S1.
1. Furtado M, Katzman MA. Highlighting inflammatory markers in anxiety disorders. http://atlasofscience.org/highlighting-inflammatory-markers-in-anxiety-disorders/
2. Katzman MA, Bilkey T, Chokka P, Fallu A, Klassen LJ. Letter to the Editor: Re: Paris J, et al. Perspective: Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed? Can J Psychiatry 2015; 60(7):324-328. Accepted to Canadian Journal of Psychiatry.
3. Ristevska I, Armata RS, D’Ambrosio C, Furtado M, Anand L, Katzman MA. Xerostomia: Understanding the diagnosis and treatment of dry mouth. Journal of Family Medicine and Disease Prevention. 2015;1:2.
4. Katzman MA, Furtado M, Copeland A, Tsirgielis D, D’Ambrosio C, Epstein I. A Review of the Current Clinical Use of Quetiapine and Extended Release Quetiapine in the Management of the Anxiety and Related Disorders. Current Psychopharmacology 2014, 3 (2):113-125.
5. Katzman MA. Managing major depressive disorder through the use of adjunct therapies. Psychiatry Research, 2014, 220 (Suppl 1), S1-2.
6. Katzman MA, Anand L, Furtado M, Chokka P. Food for thought: Improving management algorithms for major depressive disorder. Psychiatry Research, 2014, 220 (Suppl 1), S3-14.
7. Epstein I, Szpindel I, Katzman MA. Pharmacological Approaches to Manage Persistent Symptoms of Major Depressive Disorder: Rationale and Therapeutic Strategies. Psychiatry Research, 2014, 220 (Suppl 1), S15-33.
8. Katzman MA, Furtado M, Anand L. Acne as a possible adverse effect of duloxetine. Bulletin of Clinical Psychopharmacology 2014, 24(4): 408-410.
9. Katzman MA, Sternat T. A review of Concerta (OROS MPH) CNS Drugs. 2014 Nov;28(11):1005-33. doi: 10.1007/s40263-014-0175-1.DOI 10.1007/s40263-014-0175-1
10. Katzman MA, Pawluk EJ, Tsirgielis D, Anand L, Furtado M, Iorio C. Beyond chronic pain: how best to treat psychological comorbidities. Journal of Family Practice. 2014, 63(5), 260-264.
11. Sternat T, Lodzinski A, Katzman MA. Hedonic tone: A bridge between the psychobiology of depression and its comorbidities. J Depress Anxiety 2014: 3 (1): 1-8.
12. Carter J, Gerbarg PL, Brown RP, Ware RS, D’Ambrosio C, Anand L, Dirlea M, Vermani M, Katzman MA. Multi-component Yoga Breath Program for Vietnam veteran Post Traumatic Stress Disorder: randomized controlled trial. J Trauma Stress Disor Treat 2013: 2(3): 1-10.
13. Khamba B, Aucoin M, Lytle M, Vermani M, Maldonado A, Iorio C, Cameron C, Tsirgielis D, D’Ambrosio C, Anand L, Katzman MA. Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants. J Altern Complement Med. 2013 Jun 21.